Patent Assignment
Reel/Frame 048960/0213
Security Interest
Recorded: 2019-04-22
Pages: 8
Assignor
BIOTHERANOSTICS, INC.
Executed: 2019-04-22
Assignee
INNOVATUS LIFE SCIENCES LENDING FUND I, LP
777 THIRD AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties
(29)
Predicting Outcome with Tamoxifen in Breast Cancer
Predicting breast cancer treatment outcome
Identification of tumors
Application:
11/145,307 →
Publication:
US 2006/0094035
Identification of Tumors and Tissues
Application:
11/422,056 →
Publication:
US 2007/0020655
Grading of Breast Cancer
Prostate Cancer Survival and Recurrence
Application:
12/391,224 →
Publication:
US 2010/0047787
Tumor Grading and Cancer Prognosis
Grading of Breast Cancer
Application:
13/083,500 →
Publication:
US 2011/0183858
Identification of Tumors
Application:
13/626,078 →
Publication:
US 2013/0023441
Post-Treatment Breast Cancer Prognosis
Application:
13/914,617 →
Publication:
US 2013/0281502
Neuroendocrine Tumors
Application:
14/223,473 →
Publication:
US 2014/0349856
Predicting Breast Cancer Recurrence
Application:
14/483,108 →
Publication:
US 2015/0203921
Predicting Likelihood of Response to Combination Therapy
Determining Tumor Origin
Grading of Breast Cancer
Tumor Grading and Cancer Prognosis
Application:
15/242,346 →
Post-Treatment Breast Cancer Prognosis
Integration of Tumor Characteristics with Breast Cancer Index
Identification of Tumors
Identification of Tumors and Tissues
Prostate Cancer Survival and Recurrence
Application:
15/470,818 →
Publication:
US 2018/0051342
Tumor Grading and Cancer Prognosis
Application:
15/473,472 →
Determining Tumor Origin
Application:
15/582,125 →
Publication:
US 2018/0073085
Neuroendocrine Tumors
Tumor Grading and Cancer Prognosis
Predicting Breast Cancer Treatment Outcome
Application:
15/807,474 →
Publication:
US 2018/0127834
Predicting Breast Cancer Recurrence
Application:
61/876,757 →
Integration of Tumor Characteristics with Breast Cancer Index
Application:
62/255,260 →
Integration of Tumor Characteristics with Breast Cancer Index
Application:
62/265,964 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Feb 22, 2021
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: BIOTHERANOSTICS, INC.
Reel/Frame 055357/0691 →
Security Interest
Apr 5, 2021
From: BIOTHERANOSTICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 055818/0519 →
Assignment of Assignor's Interest
Apr 12, 2021
From: ERLANDER, MARK G.; MA, XIAO-JUN
To: BIOTHERANOSTICS, INC.
Reel/Frame 055896/0333 →
Assignment of Assignor's Interest
Apr 12, 2021
From: SGROI, DENNIS
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 055896/0513 →
Assignment of Assignor's Interest
May 26, 2021
From: ERLANDER, MARK G.; MA, XIAO-JUN
To: AVIARADX, INC.
Reel/Frame 056354/0090 →
Merger and Change of Name
May 26, 2021
From: AVIARADX, INC.; BIOTHERANOSTICS, INC.
To: BIOTHERANOSTICS, INC.
Reel/Frame 056354/0401 →
Assignment of Assignor's Interest
Jun 21, 2021
From: SCHNABEL, CATHERINE; ZHANG, YI; ERLANDER, MARK
To: BIOTHERANOSTICS, INC.
Reel/Frame 056608/0046 →
Assignment of Assignor's Interest
Jun 21, 2021
From: SGROI, DENNIS C.
To: THE GENERAL HOSPITAL
Reel/Frame 056608/0054 →
Security Interest
Oct 12, 2021
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 057787/0526 →
Security Interest
Oct 11, 2022
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 061639/0513 →
Change of Address
Jun 24, 2024
From: BIOTHERANOSTICS, INC.
To: BIOTHERANOSTICS, INC.
Reel/Frame 067824/0243 →
Security Interest
Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →